OCD in animal models using quinpirole as dopaminergic inductor of perseverative behaviour  by Campos-García Rojas, C. et al.
Rev Med Hosp Gen Méx. 2015;78(4):169--176
www.elsevier.es/hgmx
´
´
ORIGINAL ARTICLE
OCD  in animal  models  using  quinpirole  as dopaminergic
inductor of  perseverative  behaviour
C. Campos-García Rojasa, F. Jiménez-Ponceb, A. Flores-Vargasc,∗, A.P. Garcíaa
a Servicio  de  Cirugía  Experimental  del  Hospital  General  de  México  ‘‘Dr.  Eduardo  Liceaga’’,  Mexico  City,  Mexico
b Neurocirugía  Clínica,  Hospital  Ángeles  del  Pedregal,  Mexico  City,  Mexico
c Servicio  Social  en  Investigación  de  la  Universidad  Autónoma  del  Estado  de  México,  Mexico  City,  Mexico
Received 31  July  2015;  accepted  9  September  2015
Available  online  10  November  2015
KEYWORDS
Quinpirole;
Obsessive  compulsive
disorder;
Rat;
Open  ﬁeld
Abstract  In  the  reviewed  articles,  quinpirole  is  used  as  a  dopamine  D2 and  D3 receptor  agonist
to induce  persistent  behaviour  in  animal  models.  Dopamine  has  been  related  to  perseverative
behaviour.  The  perseverative  behaviour  was  observed  in  an  open  ﬁeld  with  objects  of  different
shapes and  sizes.  The  main  structures  studied  with  this  methodology  are  the  orbitofrontal
cortex, striatum,  thalamus,  basolateral  amygdala  and  nucleus  accumbens.  The  animal  models
studied comply  with  the  face,  predictive  and  construct  validity.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Published  by  Masson  Doyma  México
S.A. All  rights  reserved.
PALABRAS  CLAVE Trastorno  obsesivo  compulsivo  en  modelos  animales  utilizando  quinpirol  como
Quinpirol;
Trastorno  obsesivo
compulsivo;
Rata;
Campo  abierto
inductor  dopaminérgico  de  conducta  perseverante
Resumen  El  quinpirol  en  los  artículos  revisados,  tiene  como  objetivo  inducir  comportamiento
perseverante  en  el  modelo  animal,  ya  que  este  es  un  agonista  de  la  dopamina  a  través  de
receptores  D2 y  D3.  Se  ha  relacionado  el  papel  de  la  dopamina  con  el  comportamiento  per-
severante. Para  registrar  el  comportamiento  perseverante  el  aparato  utilizado  es  el  campo∗ Corresponding author at: Servicio Social en Investigación de la Universidad Autónoma del Estado de México, Mexico City, Mexico.
E-mail address: remediosvargas@hotmail.com (A. Flores-Vargas).
http://dx.doi.org/10.1016/j.hgmx.2015.09.002
0185-1063/© 2015 Sociedad Médica del Hospital General de México. Published by Masson Doyma México S.A. All rights reserved.
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abierto  con  reforzadores  (objetos  de  diferentes  formas  y  taman˜os).  Las  principales  estructuras
estudiadas  con  esta  metodología  son  la  corteza  orbitofrontal,  núcleo  estriado,  tálamo,  núcleo
acumbens  y  la  amígdala  basolateral.  Los  modelos  animales  estudiados,  cumplen  con  la  validez
de constructo,  apariencia  y  predicción.
© 2015  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México
S.A. Todos  los  derechos  reservados.
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introduction
bsessive  compulsive  disorder  (OCD)  has  been  extensively
tudied  using  animal  models,  and  has  focused  on  the  induc-
ion  of  this  behaviour  in  rats  (perseverative  behaviour)
ainly  using  dopamine  agonists  (D2/D3)  such  as  quinpirole
QP)  and  serotonin  agonists  (5HT1A)  such  as  8-hydroxy-2-(di-
-propylamino)  tetralin  (8-OH-DPAT).
In  this  review,  we  focused  on  quinpirole  because  of  its
ole  as  a  dopamine  D2 and  D3 receptor  agonist  that  induces
erseverative  behaviour  in  animal  models.  Dopamine  has
een  related  to  perseverative  behaviour.
We  studied  the  use  of  QP  as  an  inducer  of  perseverative
ehaviour  (PB)  in  animal  models  from  a  methodologi-
al  standpoint,  considering  different  ways  to  validate  the
odel,  as  well  as  the  neurological  system  studied,  the
evice  for  evaluating  the  induced  behaviour,  the  type  of
nimal  used  and  the  results  obtained.1
ethodologies used in the study of OCD in
nimal models using quinpirole
he  aim  of  the  reviewed  studies  is  to  determine  the  role  of
opamine  in  the  development  of  perseverative  behaviour  in
nimal  models  designed  to  show  its  association  with  OCD.
In  some  cases,  OCD  must  be  studied  using  animal  models,
nd  for  this  purpose  experimental  studies  with  different
trategies  are  used.  de  Haas  observed  the  behaviour  of
ats  immediately  after  administration  of  QP  and  recorded
heir  behaviour  in  the  open  ﬁeld  for  50  min.  Other  authors
dministered  QP  directly  into  target  structures  by  intracra-
ial  injection,  for  example,  orbitofrontal  cortex  (OFC),
ucleus  accumbens  (NA)  and  basolateral  amygdala  (BLA),2
nd  another  authors  previously  injured  the  structure  and
hen  compared  behaviour  between  groups.
de  Haas  et  al.  used  two  different  phases  for  their
esign,  the  ﬁrst  consisting  of  2  groups,  1  treated  with  QP
nd  another  with  0.9%  physiological  saline  solution  (SS).
hey  recoded  the  behaviour  of  both  groups  for  1  h  and
mmediately  after  treatment.  In  a  second  phase,  the  treat-
ents  are  stopped,  but  SS  is  still  administered  to  both
roups,  thus  resulting  in  four  groups;  SS-SS,  QP-QP,  QP
nd  QP-SS-injection  free.  All  groups  underwent  stereotactic
icro-dialysis  of  the  NA.
Other  researchers7 formed  2  groups,  1  treated  with  QP
nd  1  with  SS,  and  conducted  the  experiment  in  3  phases,
he  ﬁrst  being  induction  of  PB;  a  second  phase  consisting  of
raining  intracranial  self-stimulation  (ICSS)  of  the  cortico-
triatal-thalamocortical  circuit  (reward  pathway),  and  in
he  third  phase  the  pattern  of  behaviour  was  recorded  while
b
t
d
carrying  out  the  ICSS.  In  this  study,  the  frequency  and  veloc-
ty  at  which  the  rat  returns  to  its  home  base  (HB),  and  the
requency  with  which  it  visits  more  places  before  returning
o  HB  are  evaluated.
Ahmad,  meanwhile,  developed  a  different  approach  to
he  ﬁrst  part  of  the  experiment,  which  consisted  of  apply-
ng  8  injections  to  2  different  groups;  1  treated  with  QP  and
nother  with  8-OH-DPAT  at  a  dose  equal  to  QP  (chronic).  In
he  second  part  (injections  9  and  10),  they  switched  groups
nd  applied  the  treatment  following  the  8-OH-DPAT  scheme
acute  challenge).  After  each  treatment,  the  behaviour  of
he  rats  was  recorded  on  videotape  for  55  min,  evaluating
ocomotive  activity  by  measuring  the  distance  and  registe-
ing  the  paths  travelled.3
uinpirole as an inducer of persistent
ehaviour (OCD)
t  has  been  shown  that  perseverative  behaviour  in  rats  is  sim-
lar  to  obsessive-compulsive  disorder  in  humans  and  can  take
any  forms.  To  induce  PB  in  animals,  researchers  have  used
P,  a  dopamine  receptor  agonist  (D2/D3)  with  the  following
ction.
Dopamine  acts  at  different  locations  of  the  central
ervous  system,  involving  different  circuits,  such  as  cor-
ex,  striatum,  globus-pallidus,  substantia-nigra,  thalamus,
ortex  and  cortex,  striatum,  globus-pallidus,  subthalamic
ucleus  substantia-nigra,  thalamus,  cortex.  The  stimulating
ffect  of  dopamine  in  the  aforementioned  circuits  facili-
ates  activation  of  the  thalamus-cortex  circuit;  however,
ctivation  of  D2  receptors  in  striatopallidal  neurons  inhibits
rojections,  causing  decreased  motor  activity.4
QP  exerts  its  effect  on  the  neurotransmission  of  several
rain  regions,  including  the  OFC.  This  effect  is  produced
y  reducing  basal  acetylcysteine  concentrations  in  the  NA,
hus  causing  glutamatergic  changes  that  induce  changes  in
cetylcholine  (ACh),  which  modulates  postsynaptic  recep-
ors  and  their  connections.  This  may  be  related  in  some  way
o  the  process  of  care  approach.4
Chronic  administration  of  QP  in  laboratory  animals  causes
epetitive  behaviour,  deﬁciency  in  performance,  decreased
recision  for  tasks,  increase  omissions  and  decreased  devel-
pment  for  completing  tasks.4
Repeated  administration  of  D2  dopamine  agonists  causes
eceptor  supersensitivity  in  a  process  known  as  receptor
mprinting,  which  is  the  mechanism  responsible  for  some
ehaviours  generated  after  administration  of  QP.  This  recep-
or  supersensitivity  is  known  to  occur  in  some  psychiatric
isorders  such  as  schizophrenia,  OCD  and  dyskinesias  asso-
iated  with  neurological  motor  disorders.  Similar  disorders
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are  also  known  to  occur  in  QP-sensitized  animals,  in
which  stereotypes,  antinocioception,  locomotive  activity,
impaired  memory  and  learning,  and  even  atypical  vertical
leaps  are  observed.  Strangely,  alterations  that  reduce  loco-
motive  activity  for  the  ﬁrst  15  min  following  application  and
then  increases  it  after  the  second  hour  post-administration4
have  also  been  observed
In  animal  models  of  OCD/dopamine,  exposure  to  QP  is
generally  chronic,  at  a  dose  ranging  from  0.2  to  6  mg/kg,
with  an  average  of  2.3  mg/kg  and  mode  of  0.5  mg/kg.  QP
is  usually  administered  twice  weakly,  and  the  treatment
lasts  4,  5  and  up  to  8  weeks,  being  4  weeks  the  most
frequently  used  scheme.  The  drug  is  usually  given  by  sub-
cutaneous  injection  in  the  inter-scapular  region,  but  is  also
used  intraperitoneally.  It  is  used  as  a  dilution  in  SS.1--7
Animal models
This  can  be  deﬁned  as  the  experimental  preparation  that
takes  place  in  a  species  with  the  purpose  of  studying  a  phe-
nomenon  that  occurs  in  other  species.  This  concept  is  also
developed  in  psychiatry,  which  has  widely  used  the  rat  as
a  model  of  different  diseases,  particularly,  OCD.  We  found
that  most  authors  prefer  this  species,  but  the  use  of  mice  is
also  proposed.1,5
Type  of  animals  used  as  a  model  for  the  study  of
OCD using  quinpirole  as  inductor  of  persevering
behaviour
To  study  QP-induced  OCD,  there  is  no  preference  for  the
use  of  a  speciﬁc  strain  of  rat;  the  use  of  male  Long  Evans
and  Wistar  strains  is  more  extensive,  but  it  is  interesting  to
note  that  de  Haas  used  female  mice  and  studied  2  different
strains  (A/J  and  C57BL-6).  The  use  of  mice  is  rare;  male  rats
are  usually  used  and  females  are  avoided  because  of  the
relationship  between  hormones  and  behaviour.6
The  weight  of  rats  varies  from  160  to  300  g.  None  of  the
studies  reviewed  reversed  the  observation  cycle  and  a  12-h
light/dark  cycle  was  used  in  all.1--7
Validity of animal models for the study of OCD
using quinpirole
Developing  a  valid  animal  model  requires  the  signs  in  the
induced  animals  to  be  at  least  reasonably  similar  to  those
observed  in  the  modelled  disease,  and  that  the  treatment  is
effective  in  reversing  those  signs.1
To  achieve  such  validity,  the  model  must  have  face,  pre-
dictive  and  construct  validity.1
Face  validity  refers  to  a  phenomenological  similarity
between  the  model  and  the  simulated  disorder.  Ideally  the
model  should  reproduce  the  disorder  condition  from  its  aeti-
ology,  symptoms,  treatment  and  physiological  bases.  The
predictive  validity  means  that  the  performance  of  the  model
tests  are  able  to  predict  the  performance  of  the  modelled
conditions,  and  construct  validity  establishes  a  theoretically
rational  reference  and  depends  on  the  degree  of  homology
between  the  modelled  behaviour  and  the  behaviour  model.1
Animal  models  using  QP  for  studying  OCD  meet  face,  pre-
dictive  and  construct  validity  as  follows.
a
a
t
a171
ace  validity
he  use  of  QP  to  model  OCD  in  animals  complies  with  face
alidity  criteria,  since  the  induction  of  persistent  behaviour
s  achieved  in  all  cases  in  rats,  which  is  similar  to  that
bserved  in  OCD,  and  is  different  from  the  groups  treated
ith  SS.1--7
onstruct  validity
vidence  has  conﬁrmed  that  QP  is  a  dopamine  agonist
D2/D3).  This  drug  induces  changes  in  brain  neurotransmis-
ion  areas  such  as  OFC,  NA,  thalamus  and  globus  pallidus,
tructures  directly  related  to  anxiety  disorders  in  humans,
articularly  OCD.
redictive  validity
o  achieve  predictive  validity  in  QP/OCD  models,  selective
erotonin  reuptake  inhibitors  (SSRIs)  and  antipsychotics  are
sed.  Exposure  to  these  drugs  in  animals  after  induction
f  PB  with  QP  re-establishes  their  normal  behaviour.  Con-
rol  groups  were  also  formed  in  which  only  SS  is  given  and
ompared  with  the  QP  group,  observing  differences  in  the
ehaviour  of  both  groups.5,6
Another  way  to  achieve  predictive  validity  is  by  forming
P-induced  PB  groups,  and  SS-treated  groups  with  nor-
al  behaviour.  Subsequently,  a  crossover  is  made,  which
everses  induced  behaviour  in  QP  groups  and  produces  PB
n  the  groups  treated  with  QP.2,6
eurological systems in OCD targeted in
nimal models using quinpirole
he  neurological  systems  studied  using  QP  include  the
rbitofrontal  cortex,  basolateral  amygdala,  the  accumbens
ucleus  and  the  so-called  reward  circuitry  or  security-
otivation,  composed  by  cortex,  striatum  and  thalamus,
hich  is  a  circuit  that  involves  neurotransmitters,  dopamine
D2/D3),  and  serotonergic  5HT1A.1--7
evices used to record quinpirole-induced
ersistent  behaviour (OCD) in animal models
he  device  used  in  all  the  reviewed  articles  was  the  open
eld,  but  with  variations  in  its  design.
The  open  ﬁeld  can  be  designed  with  an  area  of
0  cm  ×  80  cm  ×  80  cm  without  walls,  elevated  60  cm  off  the
round.  The  surface  is  divided  in  25  locales  and  incorporates
 objects  measuring  4  cm  ×  4  cm  ×  4  cm,  2  of  them  metal-
ic  and  pyramid-shaped,  1  box-shaped  transparent  shelter
ade  of  PET  (polyethylene  terephtalate),  and  1  made  of
olycarbonate.5
A  variant  of  the  open  ﬁeld  without  walls  and  60  cm
levation  consists  of  a  160  cm  ×  160  cm  surface  divided
nto  25  locales.  Objects  are  also  used,  but  unlike  the
bove  model,  glass  boxes  measuring  8  cm  ×  8 cm  ×  7.5  cm
re  placed  in  the  corners  and  open  midﬁeld.2 There  is  a
hird  variant  of  the  elevated  open  ﬁeld  with  no  walls  and
n  area  of  160  ×  160  ×  160  cm  which  uses  only  2  objects
172
 
C.
 Cam
pos-G
arcía
 Rojas
 et
 al.
Table  1  Animal  models  for  the  study  of  OCD  using  dopaminergic  and  open  ﬁeld.
Authors  Target  System  studied  Methodology  Induction  of
persistent
behaviour
Apparatus  Species  Model  validity  Conclusions  Remarks
de  Haas  et  al.5 Compare  QP
behavioural
effect  in  2
different
strains  of
female  mouse
•  Dopaminergic
study
• Immediately
after  injection,
the  rat  is
placed  in  the
open  ﬁeld
• Behaviour  is
recorded  for
50  min  with
Ethovision  3.1
•  Activity  was
measured  in
12-h  light/dark
cycles
• QP
•  Twice  a  week  for
4  weeks
• Intraperitoneal  in
SS,
•  Group  1:  1  mg/kg
•  Group  2:  3  mg/kg
•  Group  3:  6  mg/kg
•  Group  4:  SS
• Open  ﬁeld
(80  cm  ×  80  cm)
•  Divided  into
25  locales
• No  walls
• Raised  ﬂoor
60  cm
•  4 objects
(4  cm  ×  4 cm
×  4  cm)  or  2
metal
pyramids,  or  1
transparent
PET  house  or  1
PVC  shelter
• Female  mouse
(A-J  and
C57BL-6J
strains)
• 3--4  months
old
• Face  validity:
QP-treated  mice
developed
persistent
behaviour
•  Construct  validity:
QP  agonist  D2/D3
•  Predictive
validity:  persistent
behaviour  reverts
with  SSRI
•  AJ  strain  develops  more
sensitivity  to  QP-induced
PB  vs.  C57BL-6J  strain.
• Mice  are  used  as
animal  model  instead
of  rats
•  The  mice  used  are
female
•  Does  not  indicate  the
weight  of  mice
•  Treatment  with  SSRIs
post  QP  group  is  missing
•  Day  treatment  (no
reversed  light/dark
cycle)
Dvorkin  et  al.2 Determine  the
participation
of  NA,  OFC  and
BLA  in
persevering
behaviour  in
rats
•  OFC
•  BLA
•  NA
• Injury  by
intracranial
injection  of
NMDA  in  OFC,
NA  and  BLA
•  Injury  of  at
least  55%  of  the
structure
conﬁrmed  by
histopathology
•  Rats  treated
with  SS  and  QP
•  Measurements
in  daylight
hours  (12-h
light/dark
cycles)
•  QP
•  Twice  a  week,
subcutaneous
•  0.5  mg/kg  ×  8
weeks
• Open  ﬁeld
(160  cm  ×  160
cm)
•  Divided  into
25  locales
• No  walls
• Raised  ﬂoor,
60  cm
•  4 glass  boxes
8 cm  ×  8  cm
×  7.5  cm
•  Two  placed  in
corners  and  2 in
the  centre
• Ethovishion®
•  168  Long
Evans  rats
•  250--300  g
• Face  validity:
QP-treated  rats
developed
persistent
behaviour
•  Construct  validity:
QP  agonist  D2/D3
•  Predictive
validity:  8  groups
are  formed,  4  with
SS  and  4 with  QP
•  The  BLA  has  no  effect  on
compulsive  behaviour
(review)
•  QP  induces  behaviour  by
NA  inhibition;  NA  is
probably  the  site  of
negative  feedback  control
of  the  PB
•  The  NA  PB  controls
intensity  of  the  behaviour
•  The  impact  of  the  reward
and  reinforcement  of  the
effects  of  the  stimulus  is in
the  NA
• The  functional  pattern  of
CFO  is to  control  the
intensity  of  PB,  it relates  to
focus  on  reaching  a  goal
•  The  NA  controls  the
intensity  of  motor  activity
behaviour
• The  sex  of  the  rats  is
not  speciﬁed
• Day  treatment  (no
reversed  light/dark
cycle)
O
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Table  1  (Continued)
Authors  Target System  studied Methodology  Induction  of
persistent
behaviour
Apparatus  Species  Model  validity Conclusions  Remarks
de  Haas  et  al.6 NA  determines
participation
in  PB
• NA  It  was  divided
into 2 phases
• Phase  1,  total
rats  were
divided  into  2
groups:
1.  N:  24  rats
were  injected
QP 0.5  mg/kg
SC  twice  a
week  for  5
weeks
2.  N:  8 rats  SS
twice  a  week
for  5  weeks
After  each
injection  the
rats  were
monitored  for
1  h.  Ethovishion
•  Phase  2,
group  receiving
continuous  SS
SS  and
QP-treated
group  were
divided  into  4
different
groups:
1.  SS--SS
2.  QP--QP
3.  QP--SS
4.  QP
• The  4 groups
underwent  NA
surgery,
stereotaxic
microdialysis
•  Measurements
in12-h
light/dark
cycles
•  QP
•  Twice  a  week  × 5
weeks
•  0.5  mg/kg  SC
• Open  ﬁeld
(160 cm  ×  160  cm)
•  Built  with
Plexiglas
• No  walls
• Raised  ﬂoor
60  cm
•  Two  objects
• 32  male
Sprague  Dawley
rats
•  200--250  g
•  4  rats  per
cage
• Face  validity:
QP-treated  rats
developed
persistent
behaviour
•  Construct  validity:
QP  D2/D3  agonist
•  Predictive
validity:  4  different
groups  (1)  SS--SS,
(2)  QP--QP,  (3)
QP-SS,  (4)  QP-NO  or
compulsive
behaviour  with  the
use  of  SSRIs  and
antipsychotics  was
reversed
• It  was  demonstrated  that
rats  treated  chronically
with  QP-PB  develop  OCD
characteristic  similar  to
human
•  The  cessation  of
treatment  with  QP  results
in  a  rapid  recovery  of
normal  behaviour
•  The  microdialysis  after
treatment  with  QP  reveals
changes  in  dopamine  levels
in  the  NA  indicating  the
role  of  dopamine  in  the  CP
•  The  QP-induced  behaviour
mimics  only  compulsory
part  of  OCD
• Groups  of  different
sizes
•  The  sex  of  the  rats  is
not  speciﬁed
• Check  the  behaviour
took  place  in  daylight
hours  (not  reverse
light/dark  cycle)
174
 
C.
 Cam
pos-G
arcía
 Rojas
 et
 al.
Table  1  (Continued)
Authors  Target  System  studied  Methodology  Induction  of
persistent
behaviour
Apparatus  Species  Model  validity  Conclusions  Remarks
Schmidt  et  al.7 Investigate
whether
deregulation  is
involved  in
dopamine
reward
circuitry  of  the
rat  model  of
OCD  with  QP
•  Reward-circuit  Three  phases
•  Phase  1:
induction  of  PB
•  Phase  2:
induction
(training)  of
intracranial
self-stimulation
(ICSS)
•  Phase  3:  ICSS
testing  sessions
Groups
•  Control  group:
treated  with  SS
•  Experimental
group  treated
with  QP
Electrode
implantation
between
injections  7  and
9
ICSS  training
after injection
10
Behavioural
criteria  for
recording:
•  Criterion  1.
Number  of
times  the  rat
returns  to  the
home  base  (HB)
•  Criterion  2:
Speed  at  which
the  rat  returns
to  HB
•  Criterion  3:
Number  of
places  it  visits
before
returning  to  HB
Measurements
in  daylight
hours  (12-h
light/dark
cycles)
Behavioural
assessment
time:  30  min
• QP
•  Twice  a  week
•  QP  in  a  0.5  mg/ml
SS
•  0.5  mg/kg  SC  in
the  nape  of  neck
Control  animals
were  injected  with
the  same  volume  of
QP  using  SS
injections  instead
• Open  ﬁeld
(140  cm  ×  140  cm)
•  Walls  of  20  cm
•  Glass  surface
•  4 objects
(white  Plexiglas
boxes  with
different  sizes
and  colours),
placed  in
different
positions
•  Videotaping
TSE  VideoMot  2
system;
Technical  &
Scientiﬁc
•  Equipment,
Germany
•  Total  distance
travelled
•  Frequency  of
pauses  at  each
object
•  Periods  of  no
locomotion
•  Self-
stimulation
device  Multi
Channel
Systems  GmbH,
Germany®
camera
28  cm  ×  28  cm  ×  24  cm
and  0.1  ms
pacing  pulses  of
constant
duration
•  Videotaping
TSE  Systems
Germany,  with
computer
interface
STG4004®
•  Male  Wistar
rats
•  160--180  g
• Face  validity:
QP-treated  rats
developed
persistent
behaviour
•  Construct  validity:
QP  D2/D3  agonist
•  Predictive
validity:  both
groups  received
self-stimulation  and
only  1  QP
• Chronic  treatment  with
QP-PB  in  rats
•  QP  increases  locomotion
•  In  rats  treated  with  QP
the  effect  of
d-amphetamine  reward  was
higher  than  the  control  rats
•  It  is  suggested  that
chronic  treatment  with  QP
induces  changes  in  the
reward  circuit
• No  reversed
light/dark  cycle
•  Treatment  and
experiments  are
performed  during  light
hours
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Table  1  (Continued)
Authors  Target System  studied Methodology  Induction  of
persistent
behaviour
Apparatus  Species  Model  validity Conclusions  Remarks
Alkhatib  et  al.3 Determine
whether  QP
and  8-OH-DPAT
CP produce
effects
through  a
common
mechanism
•  Bark-striatal-
thalamus-cortex
circuit
•  Security-
motivation  circuit
(danger-warning)
dopamiergic-
serotonergic
(increased  D,
insufﬁcient
negative  feedback
serotonergic  or
both)
• Phase  1:  QP
injections  1 to
8  two  in  groups
and  8-OH-DPAT
(according  to
QP  treatment
regimen)
• Phase  2:
crossover
injections  9 and
10
•  n  = 12/group
• Randomized
•  Videotaping
open  ﬁeld  for
55  min
•  Visits  and
stops  were
measured
•  Locomotor
activity,
distance
travelled,  and
paths  were
quantiﬁed
•  Measurements
in  daylight
hours  (12-h
light/dark
cycles)
•  QP  0.2  mg/kg  SC
•  8-OH-DPAT
1  mg/kg  SC
• Nape  of  neck
•  Twice  a  week
• Open  ﬁeld
(160 cm  ×  160  cm)
•  Walls  60  cm
•  Blue  surfaces
• Divided  into
25  locales
•  4 objects
(Plexiglas  boxes
8  cm  × 8  cm  ×  7.5  cm).
Two  objects
placed  in  the
corners  and  2 in
the  centre
• Ethovision  3.1
•  Male
Long-Evans  rats
•  250--300  g
•  Rats  were
treated  2--3  min
daily  5  days
before  the
experiment
•  Face  validity:
QP-treated  rats
developed
persistent
behaviour
•  Construct  validity:
QP  D2/D3  agonist
•  8-OH-DPAT  as
5HT1A agonist
•  Predictive
validity:  SS
injections  were
used  in  the  same
volume  and
crossover  QP-PB
reversed
• The  use  of  both  drugs  (QP
and  8-OH-DPAT)  produces
synergy  in  the  induction  of
PB,  and  also  separately
•  8-OH-DPAT  is signiﬁcantly
more  effective  in  inducing
PB
•  The  chronic  effect  of
8-OH-DPAT  in  PB  does  not
replace  the  QP-PB  and  thus
the  effect  of  8-OH-DPAT
does  not  cross-sensitize
with  QP
• In  the  group  treated  with
chronic  QP,  PB  is  not
attenuated  after  8-OH-DPAT
use  but  PB  is  higher  after
application  of  QP
• 8-OH-DPAT  and  QP-PB
induced  PB  by  2
independent  mechanisms
•  8-OH-DPAT  and  QP
produce  dysfunction  in
different  parts  of  the
neural  circuit  cortex-
striatal-thalamus-cortex
(dopamine-serotonin)
• No  reversed
light/dark  cycle
•  Treatment  and
experiments  are
performed  in  light
hours
Abbreviations: BLA, basolateral amygdala; OFC, orbitofrontal cortex; PB, persevering behaviour; HB, home base; ICSS, intracranial self stimulation; SSRIs, selective serotonin reuptake
inhibitor; NA, nucleus accumbens; QP, quinpirole; SC, subcutaneous; SS, physiological saline; OCD, obsessive compulsive disorder; 5HT1A, serotonin; 8-OH-DPAT, 8-hydroxy-2-(di-n-
propylamino) tetralin, QP-PB, quinpirole-induced preserving behaviour.
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f  indeterminate  size.  These  3  devices  are  constructed  of
lexiglas.  Using  the  same  surface  dimensions,  the  design
an  have  blue-surfaced  60  cm  high  walls,  divided  into  25
ocales.  This  design  also  has  four  objects  consisting  of
 cm  ×  8  cm  ×  7.5  cm  Plexiglas  boxes  (2  placed  at  the  corners
nd  2  in  the  centre  of  the  open  ﬁeld).3
The  main  differences  between  open  ﬁeld  devices  con-
erns  the  presence  or  absence  of  walls  and  the  number  of
bjects,  most  of  which  are  made  of  Plexiglas,  although  other
aterials  such  as  glass  are  also  used.  Dimensions  also  vary
reatly,  ranging  from  80  cm  ×  80  cm  to  160  cm  ×  160  cm,  the
atter  being  by  far  the  most  common  (3  of  5  devices).3
Another  open  ﬁeld  design  uses  glass  for  the  base.  It
as  a  140  cm  ×  140  cm  surface,  with  20  cm  high  walls  and
 Plexiglas  objects  of  different  sizes  and  colours,  placed  in
ifferent  positions.7
To  record  the  behaviour  in  the  open  ﬁeld,  video  and  com-
uter  systems  such  as  Ethovision  3.1®,  Multi  Channel  Systems
mbh  Germany® and  STG4004® computer  interfaces  are
sed.1--7
he quinpirole D2/D3 agonist and its role in
he development of perseverative behaviour
n animal models
tudies  have  shown  that  QP-induced  behaviour  in  mice  is
train-dependent.  Therefore,  there  is  a  genetic  factor  that
nﬂuences  the  presence  of  PB.5 Compulsive  behaviour  has
lso  been  shown  to  be  regulated  by  different  brain  nuclei,
nd  the  basolateral  amygdala  has  no  inﬂuence  on  persever-
ng  behaviour.2
The  NA  inhibition  is  the  mechanism  by  which  QP  induces
B,  so  it  is  probably  the  negative  feedback  site.  It  has  also
een  shown  that  OFC  is  related  to  focusing  on  achieving  a
oal  in  the  open  ﬁeld.2
Increasing  NA  dopamine  levels  by  administration  of  QP
hrough  microdialysis  in  rat  brains  suggests  that  QP  mimics
nly  the  persevering  part  of  the  PB  in  rats.6
The  use  of  d-amphetamine  as  a  chronic  treatment  to
everse  the  behavioural  effects  of  QP  suggests  that  QP
nduces  changes  in  the  reward  circuit  and  also  increases  the
ocomotion  of  treated  animals.7
Combined  use  of  QP  and  8-OH-DPAT  has  a  synergic  effect
n  PB  induction  in  rats;  the  8-OH-DPAT  being  more  the  more
ffective  component.  Each  of  these  drugs  induces  the  same
ehaviour  by  different  specialized  neural  circuits.3
onclusions
e  conducted  an  extensive  search  for  studies  of  quinpirole
nd  PB  published  over  the  past  5  years,  and  obtained  only
even  references.  This  shows  that  very  little  information  has
een  published  on  this  subject  in  recent  years,  although  we
elieve  that  this  information  gives  important  insight  into  the
ffect  of  quinpirole  on  OCD.
Various  experiments  have  shown  by  different  means  that
opamine  has  a  role  in  PB,  and  that  serotonin  has  also  a  role
n  the  ideation  that  leads  to  such  compulsive  behaviour.
Persistent  behaviour  in  mice  could  be  inﬂuenced  by
enetic  factors,  since  PB  expression  is  not  only  determined
9C.  Campos-García  Rojas  et  al.
y  QP.  This  suggests  that  bias  may  exist  in  animal  models  of
CD.  Given  that  other  studies  use  different  strains  of  rats
Wistar,  Long  Evans  and  Spraw  Dale),  all  treated  with  QP,
t  is  particularly  important  to  check  the  internal  validity  of
hese  studies.5
All  experiments  using  QP  record  behaviour  in  the  open
eld  with  objects  and  their  respective  variants.  They  also
se  a  computerized  system  for  recording  this  behaviour.1--7
Some  studies  in  animal  models  (rat)  using  QP  do  not  spec-
fy  the  sex  of  the  animals,  and  we  believe  this  may  be  a
actor  of  bias,  since  behaviour  is  probably  inﬂuenced  by
estrogen.
None  of  the  studies  analyzed  changed  sleep-wakefulness
ycle  in  the  rats.  This  raises  the  possibility  of  bias
ecause  5HT1A increases  during  sleep8 and  decreases  dur-
ng  wakefulness,  contrary  to  dopamine  that  increases  during
akefulness  and  decreases  during  sleep.9 Failure  to  invert
he  cycle  might  have  caused  dopamine9 to  be  increased  and
nteract  in  synergy  with  QP,  thus  affecting  the  predictive
alidity  of  the  model.
Regarding  the  validation  of  the  model  used  in  the  studies,
e  have  found  that  the  rat  --  QP-Open  Field  trilogy  is  a  valid
odel  for  the  study  of  OCD  and  the  involvement  of  dopamine
n  this  anxiety  disorder.
The  studies  analyzed  are  compared  in  Table  1.
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